Guangdong Hybribio Biotech Co.,Ltd. (SHE:300639)

SHE:300639 Revenue

Guangdong Hybribio Biotech had revenue of 125.83M CNY in the quarter ending March 31, 2026, a decrease of -6.14%. This brings the company's revenue in the last twelve months to 661.41M, down -13.71% year-over-year. In the year 2025, Guangdong Hybribio Biotech had annual revenue of 669.64M, down -17.89%.

• Revenue (ttm): 661.41M
• Revenue Growth: -13.71%
• P/S Ratio: 5.95
• Revenue / Employee: 303.69K
• Employees: 2,205
• Market Cap: 3.99B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	669.64M	-145.89M	-17.89%
Dec 31, 2024	815.53M	-288.93M	-26.16%
Dec 31, 2023	1.10B	-4.49B	-80.27%
Jan 1, 2023	5.60B	2.92B	109.39%
Jan 1, 2022	2.67B	1.32B	97.34%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 15, 2026

Data Sources Report a data error